Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03300999 · ClinicalTrials.gov registry record · NA
The Effects of Daily Ginger Tea Consumption in Reducing Discomfort During Menstruation
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03300999: Completed NA study, sponsored by Loma Linda University.
NCT03300999 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03300999, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of our graduate student research study is to observe the effect of drinking ginger tea daily on period discomfort.
Primary Outcome
• The Visual Analogue scale is a form of a Likert scale that gives the interviewee maximum freedom to estimate their pain intensity. The interviewee will mark a line along the 10-cm scale which they perceive corresponds best to their exact pain intensity every day for the duration of the study. A score of zero indicated no pain and a score of 10 indicated the most severe pain felt.
Interventions
- DIETARY_SUPPLEMENT ginger tea
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-11-14 |
| Est. Completion | 2018-04-02 |
| Phase | NA |
What the finished NCT03300999 record still lists
NCT03300999 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which ginger tea is the first listed.
NCT03300999 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03300999 about?
NCT03300999 is a clinical study titled "The Effects of Daily Ginger Tea Consumption in Reducing Discomfort During Menstruation". The purpose of our graduate student research study is to observe the effect of drinking ginger tea daily on period discomfort.
What is the current status of trial NCT03300999?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2017-11-14. Estimated completion is 2018-04-02.
What interventions are being tested in trial NCT03300999?
The interventions under investigation include: ginger tea (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03300999?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03300999's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI